U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details


Last Revision: March 17, 2021.

Estimated reading time: 1 minute

CASRN: 36505-84-7

image 134999311 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

Limited information indicates that maternal doses of buspirone up to 45 mg daily produce low levels in milk. Because no information is available on the long-term use of buspirone during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. A woman was taking buspirone 15 mg 3 times daily during pregnancy and postpartum. On day 13 postpartum, buspirone was undetectable in breastmilk by HPLC assay (limit of detection and time of sample not stated).[1]

Infant Levels. In the exclusively breastfed infant of a mother who was taking buspirone 15 mg 3 times daily, buspirone was undetectable in the infant's serum by HPLC assay (limit of detection and time of sample not stated) on days 13 and 21 postpartum.[1]

Effects in Breastfed Infants

Possible drug-induced seizure-like activity and cyanosis occurred in a breastfed 3-week-old whose mother was taking buspirone 15 mg 3 times daily as well as fluoxetine and carbamazepine during pregnancy and breastfeeding. The authors thought that this reaction, if drug induced, was most likely caused by fluoxetine.[1]

One exclusively breastfed 11-week-old infant was breastfed during maternal therapy with buspirone 10 mg daily and venlafaxine 300 mg daily. No adverse reactions were reported by the mother or in the medical records.[2]

Effects on Lactation and Breastmilk

Buspirone increases serum prolactin.[3-6] Galactorrhea was reported in a woman taking venlafaxine after buspirone was added to her regimen. However, when buspirone was discontinued, galactorrhea persisted.[7] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.

Alternate Drugs to Consider

Lorazepam, Oxazepam


Brent NB, Wisner KL. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr (Phila). 1998;37:41–4. [PubMed: 9475699]
Newport DJ, Ritchie JC, Knight BT, et al. Venlafaxine in human breast milk and nursing infant plasma: Determination of exposure. J Clin Psychiatry. 2009;70:1304–10. [PubMed: 19607765]
Bridge MW, Marvin G, Thompson CE, et al. Quantifying the 5-HT1a agonist action of buspirone in man. Psychopharmacology (Berl). 2001;158:224–9. [PubMed: 11713611]
Gómez-Gil E, Navinés R, Martínez De Osaba MJ, et al. Hormonal responses to the 5-HT1a agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment. Psychoneuroendocrinology. 2010;35:481–9. [PubMed: 19762159]
Maskall DD, Zis AP, Lam RW, et al. Prolactin response to buspirone challenge in the presence of dopaminergic blockade. Biol Psychiatry. 1995;38:235–9. [PubMed: 8547445]
Navinés R, Gómez-Gil E, Martin-Santos R, et al. Hormonal response to buspirone is not impaired in major depression. Hum Psychopharmacol. 2007;22:389–95. [PubMed: 17563921]
Sternbach H. Venlafaxine-induced galactorrhea. J Clin Psychopharmacol. 2003;23:109–10. [PubMed: 12544389]

Substance Identification

Substance Name


CAS Registry Number


Drug Class

Breast Feeding


Anti-Anxiety Agents

Serotonin Agonists

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK501449PMID: 30000509


Related information

Similar articles in PubMed

  • Review Dantrolene.[Drugs and Lactation Database (...]
    Review Dantrolene.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Tranylcypromine.[Drugs and Lactation Database (...]
    Review Tranylcypromine.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Prazosin.[Drugs and Lactation Database (...]
    Review Prazosin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Trihexyphenidyl.[Drugs and Lactation Database (...]
    Review Trihexyphenidyl.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Triamcinolone.[Drugs and Lactation Database (...]
    Review Triamcinolone.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...